Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Male
Behavior, Animal
Dose-Response Relationship, Drug
Cannabinoids
Hydrolysis
Arachidonic Acids
Article
Monoacylglycerol Lipases
Amidohydrolases
Glycerides
Mice, Inbred C57BL
Receptor, Cannabinoid, CB2
Mice
Piperidines
Receptor, Cannabinoid, CB1
Animals
Benzodioxoles
Endocannabinoids
DOI:
10.1038/nchembio.129
Publication Date:
2008-11-23T19:25:36Z
AUTHORS (12)
ABSTRACT
2-Arachidonoylglycerol (2-AG) and anandamide are endocannabinoids that activate the cannabinoid receptors CB1 and CB2. Endocannabinoid signaling is terminated by enzymatic hydrolysis, a process that for anandamide is mediated by fatty acid amide hydrolase (FAAH), and for 2-AG is thought to involve monoacylglycerol lipase (MAGL). FAAH inhibitors produce a select subset of the behavioral effects observed with CB1 agonists, which suggests a functional segregation of endocannabinoid signaling pathways in vivo. Testing this hypothesis, however, requires specific tools to independently block anandamide and 2-AG metabolism. Here, we report a potent and selective inhibitor of MAGL called JZL184 that, upon administration to mice, raises brain 2-AG by eight-fold without altering anandamide. JZL184-treated mice exhibited a broad array of CB1-dependent behavioral effects, including analgesia, hypothermia and hypomotility. These data indicate that 2-AG endogenously modulates several behavioral processes classically associated with the pharmacology of cannabinoids and point to overlapping and unique functions for 2-AG and anandamide in vivo.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (784)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....